Anthem (ANTM) Tops Q4 EPS by 2c

Go back to Anthem (ANTM) Tops Q4 EPS by 2c

Anthem (ANTM) PT Raised to $280 at Credit Suisse; 'Strong Operating Momentum with Numerous Developing Opportunities'

February 1, 2018 8:44 AM EST

Credit Suisse raised its price target on Anthem (NYSE: ANTM) to $280.00 (from $255.00) while maintaining a Outperform rating.

... More

Anthem (ANTM) PT Raised to $266 at Morgan Stanley

February 1, 2018 7:38 AM EST

Morgan Stanley raised its price target on Anthem (NYSE: ANTM) to $266.00 (from $247.00) while maintaining a Equalweight rating.

... More

Anthem (ANTM) PT Raised to $278 at Piper Jaffray

February 1, 2018 6:40 AM EST

Piper Jaffray raised its price target on Anthem (NYSE: ANTM) to $278.00 (from $260.00) while maintaining a Overweight rating.

... More

Anthem (ANTM) PT Raised to $286 at Citi

February 1, 2018 5:21 AM EST

Citi raised its price target on Anthem (NYSE: ANTM) to $286.00 (from $236.00) while maintaining a Buy rating.

... More

Anthem (ANTM) Appoints Bahija Jallal to Board

January 31, 2018 6:07 AM EST

Anthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.

With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More

Anthem (ANTM) Raises Quarterly Dividend 7.1% to $0.75; 1.2% Yield

January 31, 2018 6:06 AM EST

Anthem (NYSE: ANTM) declared a quarterly dividend of $0.75 per share, or $3 annualized. This is a 7.1% increase from the prior dividend of $0.70.

The dividend will be payable on March 23, 2018, to stockholders of record on March 9, 2018, with an ex-dividend date of March 8,... More